New Chinese Deals for Rio Tinto

Rio Tinto is all set to embark on a new Chinese joint venture and expand an existing one in place with Sinosteel. The Sinosteel deal involves extending the existing Channar iron ore joint venture in Australia. The expansion will help produce an extra 50 million tonnes of iron ore.

The deal signed in 1987 was originally for producing 200 million tonnes of iron ore from deposits in the Pilbara region. The JV was owned 60% by Rio Tinto and 40% by Sinosteel. It is currently producing 10 million tonnes of iron ore annually as per figures released by Rio Tinto.

The new joint venture is between Rio and the Aluminum Corp of China to explore for minerals in China, mainly copper and coking coal. This new deal should help ease tensions in China for the company as well following the recent deterioration in Chinese relations for Rio when it refused Chinalco’s bid to increase its stake in the company.

Rio Tinto is also looking at more exploration deals in other countries such as the Simandou iron ore project in Guinea.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, March 19). New Chinese Deals for Rio Tinto. AZoMining. Retrieved on April 19, 2024 from https://www.azomining.com/News.aspx?newsID=1879.

  • MLA

    Chai, Cameron. "New Chinese Deals for Rio Tinto". AZoMining. 19 April 2024. <https://www.azomining.com/News.aspx?newsID=1879>.

  • Chicago

    Chai, Cameron. "New Chinese Deals for Rio Tinto". AZoMining. https://www.azomining.com/News.aspx?newsID=1879. (accessed April 19, 2024).

  • Harvard

    Chai, Cameron. 2019. New Chinese Deals for Rio Tinto. AZoMining, viewed 19 April 2024, https://www.azomining.com/News.aspx?newsID=1879.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.